Immutep IMMP
NASDAQ IMMP
$3.56 +0.10 (+2.89%)
As of: Nov 11, 2026 · 3:59 PM EST

Immutep (IMMP) EBITDA Margin (2014 - 2017)

Updated

Immutep (IMMP) recorded EBITDA Margin of -528.27% in the year ended Jun 30, 2026, up 43.60 percentage points from -571.87% a year earlier.

Analysis

Immutep (IMMP) EBITDA Margin (2014 - 2017) Analysis & Trends

Starting with the year ended Jun 30, 2010, Immutep's EBITDA Margin history includes 13 years.

  • Annual EBITDA Margin has a four-year change of +18432.47 percentage points (years ended Jun 2022 to Jun 2026).
  • The figure for the year ended Jun 30, 2026 is the highest annual EBITDA Margin since the year ended Jun 30, 2020.
  • Per Business Quant data, IMMP's EBITDA Margin was -571.87% in the year ended Jun 30, 2025 and -18960.74% in the year ended Jun 30, 2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA Margin (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 36.69%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 32.68%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 46.88%
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 40.60%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 39.77%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 46.62%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 50.63%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 42.49%
10 Immutep 252.65 Mn 41.62 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2017 183.87%
Mar 31, 2017 -160.92%
Jun 30, 2016 -149.14%
Mar 31, 2016 -894.17%
Jun 30, 2015 -18,838.90%
Jun 30, 2014 -80,880.24%
API Access

Immutep EBITDA Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebitda-margin&ticker=IMMP&period=max&api_key=YOUR_API_KEY